GGrantIndex
Sort

261,768 grants matching gene therapy

Development Of New Chemotherapeutics For Tuberculosis

$1,829,520
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapies

$1,829,402
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies

$1,829,402
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Roles and Regulation of wild-type and mutant forms of p53

$1,829,019
Carol Prives · Columbia Univ New York Morningside · P01 · FY2019 · CA

Project 3: Breaking tolerance and improving the immune mediated response though oncolytic virus based therapy

$1,828,889
Kevin A Cassady · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA

Gene Therapy for Hemophilia

$1,828,821
Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2008 · HL

Circuit-based deep brain stimulation for Parkinson's disease

$1,828,470
Jerrold L Vitek · University Of Minnesota · P50 · FY2017 · NS

Structure and function of eukaryotic DNA transposases

$1,828,428
Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Translational Gene Therapy for CNGB1 Retinitis Pigmentosa

$1,828,029
Simon Petersen-Jones · Michigan State University · R24 · FY2021 · EY

GENE THERAPY USING HEMATOPOIETIC STEM CELLS

$1,827,927
Children'S Hospital Los Angeles · P01 · FY2005 · HL

Cell Interactions in Three Dimensional Tissue Culture

$1,827,738
Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Immune Responses to AAV-Mediated FIX Gene Transfer

$1,827,678
Hildegund C. J. Ertl · Wistar Institute · P01 · FY2010 · HL

SPORE in Prostate Cancer

$1,827,641
William George Nelson · Johns Hopkins University · P50 · FY2016 · CA

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

$1,827,591
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2022 · CA

Maximizing Local Access to Therapeutic Deliveries in Glioblastoma

$1,827,419
Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2021 · CA

Neurosurgical Oncology Unit

$1,827,359
Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

GENERAL CLINICAL RESEARCH CENTER

$1,827,311
Tufts Medical Center · M01 · FY2000 · RR

Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression

$1,827,086
Josh Levitsky · Northwestern University At Chicago · U01 · FY2023 · AI

Leveraging rare genetic etiologies to advance knowledge and treatment of neuropsychiatric disorders

$1,826,721
Christa Lese Martin · Geisinger Clinic · U01 · FY2023 · MH

Primate Lentivirus Pathogenesis

$1,826,463
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

PRECLINICAL MODELS OF ORGAN AND CELL TRANSPLANTATION TOL

$1,826,186
University Of Alabama At Birmingham · U19 · FY2001 · DK

Development of Novel Mycolytic Therapies for Lung Disease

$1,826,101
David B Peden · Univ Of North Carolina Chapel Hill · P01 · FY2019 · HL

Use of Focused ultrasound stimulated blood brain barrier opening for CNS HIV/SIV reservoir reduction

$1,825,990
Mahesh Mohan · Texas Biomedical Research Institute · R01 · FY2025 · DA

ECHO Renewal for the INSPIRE Study Cohort

$1,825,938
Tina V Hartert · Vanderbilt University Medical Center · UG3 · FY2023 · OD

SPORE in Breast Cancer

$1,825,172
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2015 · CA